Related references
Note: Only part of the references are listed.Effect of Nonadherence on Levetiracetam Pharmacokinetics and Remedial Dose Recommendations Using Monte Carlo Simulations
Janthima Methaneethorn
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2022)
What should patients do if they miss a dose? A systematic review of patient information leaflets and summaries of product characteristics
Abdullah Albassam et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Estimation of drug exposure by machine learning based on simulations from published pharmacokinetic models: The example of tacrolimus
Jean-Baptiste Woillard et al.
PHARMACOLOGICAL RESEARCH (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
What should patients do if they miss a dose of medication? A theoretical approach
Elijah D. Counterman et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2021)
How to handle the delayed or missed dose of rivaroxaban in patients with non-valvular atrial fibrillation: model-informed remedial dosing
Xiao-Qin Liu et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2021)
Medication adherence-Key considerations for clinical pharmacologists
Dyfrig A. Hughes
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
How to Handle Delayed or Missed Doses: A Population Pharmacokinetic Perspective
Jia-qin Gu et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2020)
Population Pharmacokinetics and Dosing Recommendations of Levetiracetam in Adult and Elderly Patients With Epilepsy
Maria Patricia Hernandez-Mitre et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Remedial dosing recommendations for delayed or missed doses of valproic acid in patients with epilepsy based on Monte Carlo simulations
Chen-yu Wang et al.
EPILEPSY & BEHAVIOR (2020)
Nonadherence to Antiepileptic Medications and Its Determinants among Epileptic Patients at the University of Gondar Referral Hospital, Gondar, Ethiopia, 2019: An Institutional-Based Cross-Sectional Study
Misganaw Tilahun et al.
NEUROLOGY RESEARCH INTERNATIONAL (2020)
Glomerular Filtration Rate Is a Major Predictor of Clearance of Oxcarbazepine Active Metabolite in Adult Chinese Epileptic Patients: A Population Pharmacokinetic Analysis
Wei-Wei Lin et al.
THERAPEUTIC DRUG MONITORING (2019)
Remedial dosing recommendations for delayed or missed doses of lamotrigine in pediatric patients with epilepsy using Monte Carlo simulations
Er-Qian Yu et al.
EPILEPSY & BEHAVIOR (2019)
Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens
Wei-wei Lin et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate
B. E. Gidal et al.
ACTA NEUROLOGICA SCANDINAVICA (2018)
Modeling and simulations to support dose selection for eslicarbazepine acetate therapy in pediatric patients with partial-onset seizures
Soujanya Sunkaraneni et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2018)
Population Pharmacokinetic Evaluation and Missed-Dose Simulations for Eslicarbazepine Acetate Monotherapy in Patients With Partial-Onset Seizures
Soujanya Sunkaraneni et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2018)
Population pharmacokinetic models of lamotrigine in different age groups of Chinese children with epilepsy
Zhong-bin Zhang et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters
Daniela Milosheska et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
A Tutorial on RxODE: Simulating Differential Equation Pharmacometric Models in R
W. Wang et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
Population Pharmacokinetics of Valproic Acid in Adult Chinese Epileptic Patients and its Application in an Individualized Dosage Regimen
Wei-wei Lin et al.
THERAPEUTIC DRUG MONITORING (2015)
A Population Pharmacokinetic Model of Valproic Acid in Pediatric Patients with Epilepsy: A Non-Linear Pharmacokinetic Model Based on Protein-Binding Saturation
Junjie Ding et al.
CLINICAL PHARMACOKINETICS (2015)
Effects of CYP2C19 and P450 Oxidoreductase Polymorphisms on the Population Pharmacokinetics of Clobazam and N-Desmethylclobazam in Japanese Patients With Epilepsy
Junji Saruwatari et al.
THERAPEUTIC DRUG MONITORING (2014)
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
Tracy Glauser et al.
EPILEPSIA (2013)
Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions
Jacqueline G. Hugtenburg et al.
PATIENT PREFERENCE AND ADHERENCE (2013)
The effect of poor compliance on the pharmacokinetics of carbamazepine and its epoxide metabolite using Monte Carlo simulation
Jun-jie Ding et al.
ACTA PHARMACOLOGICA SINICA (2012)
Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age
Ihab G. Girgis et al.
EPILEPSIA (2010)
Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy
Stephanie Chhun et al.
EPILEPSIA (2009)
Impact of nonadherence to antiepileptic drugs on health care utilization and costs: Findings from the RANSOM study
R. Edward Faught et al.
EPILEPSIA (2009)
Population Estimation Regarding the Effects of Cytochrome P450 2C19 and 3A5 Polymorphisms on Zonisamide Clearance
Yusuke Okada et al.
THERAPEUTIC DRUG MONITORING (2009)
Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies
Philip N. Patsalos et al.
EPILEPSIA (2008)
Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: Survey of patients with epilepsy and physicians
Collin A. Hovinga et al.
EPILEPSY & BEHAVIOR (2008)
Population estimation of the effects of cytochrome P4502C9 and 2C19 polymorphisms on phenobarbital clearance in Japanese
Shuji Goto et al.
THERAPEUTIC DRUG MONITORING (2007)
ILAE treatment guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
Tracy Glauser et al.
EPILEPSIA (2006)
The use of antiepileptic drugs - Principles and practice
JW Sander
EPILEPSIA (2004)
Population pharmacokinetic modeling of steady state clearance of carbamazepine and its epoxide metabolite from sparse routine clinical data
Z Jiao et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2004)
The relationship between poor medication compliance and seizures
JA Cramer et al.
EPILEPSY & BEHAVIOR (2002)
Share Paper
